-
Stocks to Watch for Thursday 7/14/2011: Fresh 52 Week Highs and Lows
Thursday, July 14, 2011 - 2:29am | 1820Stocks trading at or near 52-week highs and lows provide excellent trading opportunities, as volatility tends to increase at such levels. The following stocks hit new 52-week highs in Wednesday's trading session (listed from highest total volume to lowest): 1) SPDR Gold Shares (NYSE: GLD):...
-
Summer Swing 07-13-2011
Wednesday, July 13, 2011 - 6:05pm | 850Cusick's Corner The reversal in the market pulled off all gains we saw in the Midday -- told you it's an interesting week. This also highlights that tightening risk is very important going into the end of this week. I am not surprised that there was a flight for safety or aversion to adding risk...
-
Dollar down, Market up 07-13-2011
Wednesday, July 13, 2011 - 3:11pm | 980Cusick's Corner Thanks Uncle Ben. The Fed chief spoke and the market interpreted his comments as well, bullish (QE3?). You got to love expiration week, the week when anything can happen. Back when I was on the trading floor, during Expiration week we wanted risk tied up by Wednesday so that if we...
-
Options Brief: Orexigen Therapeutics
Wednesday, July 13, 2011 - 2:04pm | 71Shares of Orexigen Therapeutics (NASDAQ: OREX) are higher on the session by 4.27%, trading at $1.71. Overall put volume is now running at 3.15x the daily average, with 68% of all puts traded being purchases on the offer. 1,147 contracts have traded on the session so far. Orexigen Therapeutics,...
-
Puts Purchased on Myriad Genetics
Wednesday, July 13, 2011 - 1:32pm | 110Shares of Myriad Genetics (NASDAQ: MYGN) are lower on the session by 0.08%, currently trading at $23.69. The stock has been moving largely higher over the past four months and is currently trading above the 50-day moving average. Options traders are buying puts on the name today. A short while...
-
Stock Market Movers And Key Small Cap Alert
Wednesday, July 13, 2011 - 1:25pm | 296As the markets shoot higher on QE3 prospects, many stocks are outperforming or look ready to blast higher. Let's take a look at a few. First, notice how the U.S. Dollar is collapsing today. This is helping commodity stocks rocket higher. Chevron Corporation (NYSE: CVX) is trading at $106.29, +1.90...
-
Wednesday's Put/Call Ratio Leaders
Wednesday, July 13, 2011 - 12:29pm | 77Here are today's Put/Call Ratio leaders… 1. Meritor (NASDAQ: MTOR) 3,583 puts, 60 calls 2. Taiwan Semiconductor (NYSE: TSM) 15,796 puts, 271 calls 3. Repligen (NASDAQ: RGEN) 3,000 puts, 60 calls 4. E*Trade Financial (NASDAQ: ETFC) 3,735 puts, 75 calls 5. Allscripts Healthcare Solutions (NASDAQ:...
-
High-Flying Breakout Plays For Your Consumption
Wednesday, July 13, 2011 - 11:19am | 185Here are five plays that you need to be playing close attention to this morning. The one stock that I've already gotten into this morning was GLUU, but with the volatility associated with this play, It wouldn't surprise me if there was a few more opportunities to get in it. The remaining four...
-
Puts Purchased on Seattle Genetics
Wednesday, July 13, 2011 - 11:00am | 112Shares of Seattle Genetics (NASDAQ: SGEN) are higher on the session by 2.22%, currently trading at $20.24. The stock has been moving largely higher over the past three months and is currently trading above the 200-day moving average. Options traders are buying puts on the name today. A short...
-
Lazard Capital Upgrades Alkermes from Neutral to Buy; Stock Jumps Over 2% on the Open
Wednesday, July 13, 2011 - 9:42am | 19Lazard believes the fair value of Alkermes (NASDAQ: ALKS) is $25/share.
-
Benzinga's Top Pre-Market NASDAQ Losers
Wednesday, July 13, 2011 - 8:25am | 112Transcept Pharmaceuticals Inc (NASDAQ: TSPT) dipped 41.21% to $5.05 in the pre-market session. TSPT reported that it expects a second rejection letter from the US Food and Drug Administration. ASML Holding NV (NASDAQ: ASML) dropped 1.58% to $34.33 in the pre-market trading. ASML reported a more...
-
Goldman Sachs Provides Color on Biotechnology
Wednesday, July 13, 2011 - 8:18am | 104Goldman Sachs provided color on the biotechnology sector. Its top picks are Alexion Pharmaceuticals (NASDAQ: ALXN) and Vertex Pharmaceuticals (NASDAQ: VRTX). At the same time, the rating agency has a Sell rating on Amgen (NASDAQ: AMGN). On Tuesday, AMGN closed the day at $56.90. Its shares lost 0....
-
A Peek Into The Market Before The Trading Starts
Wednesday, July 13, 2011 - 8:07am | 376Pre-open movers US stock futures are higher this morning, after upbeat Chinese growth data. Futures on the Dow Jones Industrial Average surged 75 points to 12,488.00 and futures on the S&P 500 stock index rose 9.10 points to 1,319.80. Nasdaq 100 futures gained 17.50 points to 2,362.00. A...
-
Array BioPharma Licenses Cancer Drug ARRY-543 to ASLAN Pharmaceuticals
Wednesday, July 13, 2011 - 8:01am | 112ASLAN Pharmaceuticals Pte Ltd and Array BioPharma Inc. (NASDAQ: ARRY) today announced a license agreement to develop Array's HER2 / EGFR inhibitor, ARRY-543, currently entering Phase 2 development for solid tumors. Under the agreement, ASLAN will fund and globally develop ARRY-543 through proof...
-
UPDATE: Brean Murray Color on InterMune Initiation
Wednesday, July 13, 2011 - 7:39am | 99Brean Murray, Carret & Co., which initiated InterMune Inc. (NASDAQ: ITMN) at Buy, is providing some color on the stock. “We are initiating coverage of InterMune with a Buy rating and a $50 price target,” Brean Murray writes. “InterMune is beginning to launch Esbriet, a newly approved drug for...